New research delves into the slow ratification process of the African Medicines Agency treaty, analyzing perspectives from national regulatory agencies across 45 African countries. Enabling factors like political will and desire for harmonization contrast with challenges such as slow progress and limited understanding. Addressing these can bolster continent-wide medicine regulation, ensuring quality and accessibility for ...
Reporting by the Bureau of Investigative Journalism, in partnership with STAT, reveals that at least a dozen brands of the crucial childhood cancer drug, asparaginase, have been proven to be poor quality. In some cases, brands fell well below the standard needed to treat cancer, and many have also been found to contain contaminants such ...
This week QUAMED is organising a webinar on biological medicines. What are they, how are they made, how are they regulated and what about access to biological medicines in LMIC settings. The webinar is presented by Thomas Chattaway and it is given in English and in French. Accessible for all our members.
Be-cause Health & QUAMED literature updates Ref. Twesigye G, Hafner T, Guzman J. Making the investment case for national regulatory authorities. J Pharm Pol Practices 2021: 14-16; https://doi.org/10.1186/s40545-021-00299-7 Dear Friend, In the attached paper, Twesigye and colleagues make an important case that there is a need to support the strengthening of national regulatory authorities (NRAs), which play an ...
Please do visit on a regular basis the IDDO site for information and to download their medical product quality reports. These reports are a great source of information. In the last issue, for example, they identified over 469 relevant articles that reported on incidents related to COVID-19 medical products. The articles covered more than 534 ...
Be-cause Health & QUAMED literature updates Ref BizimanaT, Hagen N, Gnegel G, Kayumba PC, Heide L (2021) Quality of oxytocin and misoprostol in health facilities of Rwanda. PLoS ONE 16(1):e0245054 Dear Friend, I am happy to share a further work from our friends at the University of Tuebingen, on the quality and storage conditions of ...
On Wednesday we were happy to present our research on #quality in #pharmaceutical #supply in times of #COVID19, at the Virtual Meeting of #Utrecht Centre for Pharmaceutical Policy Regulation, together with #AnthonyBourasseau, RRavinetto, @ITMantwerp, @MedairInt. The meeting honoured us by awarding us for the best presentation. This encourages us to further develop our operational research ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.